Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
CMS-0057-F, the prior authorization final rule, took effect January 1, 2026
the provider does not need to be Medicare-enrolled) Receive prior authorization from your Part D plan, which is the standard pre-approval process Medicare uses for covered medications Patients who initiated GLP-1 therapy before the Bridge Program launched can still qualify if they met the BMI criteria at the time therapy was initiated, even if their current BMI is now lower (a common situation for patients who have already achieved meaningful weight loss)
Signos+ is available in 49 U.S
US$ 24.72
US$ 27.53
US$ 21.42
US$ 24.01
US$ 27.66
US$ 29.62
US$ 27.69
